Table 2.
Comparisons between schizophrenic patients with and without overweight.
| overweight (N = 53) |
Non-overweight (N = 44) |
t/X2 | p | |
|---|---|---|---|---|
| Age (year) | 40.30 ± 10.18 | 39.36 ± 9.49 | -0.466 | 0.642 |
| Sex (male/female) | 27/26 | 24/20 | 0.125 | 0.724 |
| Education (years) | 7.69 ± 3.37 | 8.43 ± 2.94 | 1.131 | 0.261 |
| Age of onset (years) | 26.13 ± 11.42 | 25.02 ± 8.62 | -0.531 | 0.597 |
| Duration of medication (years) | 12.92 ± 7.62 | 13.98 ± 8.52 | 0.642 | 0.523 |
| DAD(mg) | 409.89 ± 252.97 | 425.65 ± 296.55 | 0.282 | 0.778 |
| CRP | 2.79 ± 3.07 | 2.59 ± 5.93 | -0.216 | 0.830 |
| Mito-CD4+/CD8+ | 1.74 ± 0.73 | 1.66 ± 0.65 | -0.581 | 0.562 |
| Mito-CD3+CD4+ | 764.96 ± 320.74 | 585.66 ± 218.78 | -3.258 | 0.002** |
| Mito-CD3+CD4+ (%) | 39.83 ± 7.53 | 39.84 ± 6.86 | 0.010 | 0.992 |
| Mito-CD3+ | 1301.79 ± 431.55 | 1106.91 ± 418.30 | -2.245 | 0.027* |
| Mito-CD3+ (%) | 71.63 ± 6.56 | 71.20 ± 7.42 | -0.303 | 0.763 |
| Mito-CD3+CD8+ | 441.05 ± 180.10 | 416.34 ± 205.73 | -0.631 | 0.530 |
| Mito-CD3+CD8+ (%) | 26.55 ± 7.37 | 26.13 ± 7.64 | -0.276 | 0.783 |
| RBANS | ||||
| Immediate memory | 52.85 ± 13.25 | 53.14 ± 14.61 | 0.101 | 0.919 |
| Attention | 75.77 ± 15.19 | 74.70 ± 15.09 | -0.346 | 0.730 |
| Visuospatial | 73.74 ± 15.03 | 75.57 ± 15.48 | 0.590 | 0.557 |
| Delayed memory | 61.08 ± 16.99 | 61.75 ± 18.89 | 0.185 | 0.854 |
| Language | 68.30 ± 14.29 | 69.41 ± 13.70 | 0.387 | 0.700 |
| Total score | 59.15 ± 10.84 | 60.73 ± 11.44 | 0.695 | 0.489 |
| PANSS | ||||
| Total score | 104.77 ± 11.71 | 107.32 ± 15.34 | 0.926 | 0.357 |
| Cognitive factor | 12.30 ± 2.02 | 12.61 ± 2.46 | 0.685 | 0.495 |
| Depressive factor | 8.66 ± 2.30 | 9.02 ± 2.43 | 0.754 | 0.452 |
| Positive symptoms | 23.21 ± 3.33 | 23.75 ± 4.57 | 0.675 | 0.501 |
| Negative symptoms | 14.40 ± 3.59 | 15.30 ± 4.33 | 1.119 | 0.266 |
| Excitation | 12.02 ± 3.39 | 11.66 ± 3.19 | -0.534 | 0.594 |
DAD, Daily antipsychotic medication dosage (chlorpromazine equivalents); CRP, C-reactive protein; Mito, Mitochondria; RBANS, the Repeatable Battery for the Assessment of Neuropsychological Status; SCWT, the Stroop Color-Word Test.
*p<0.05, **p<0.01. Data were presented in Mean ± SD.